| Health / Medical Topics |
Hypoxia-Activated Prodrug TH-302
A hypoxia-activated prodrug consisting of a 2-nitroimidazole phosphoramidate conjugate with potential antineoplastic activity. The 2-nitroimidazole moiety of hypoxia-activated prodrug TH-302 acts as a hypoxic trigger, releasing the DNA-alkylating dibromo isophosphoramide mustard moiety within hypoxic regions of tumors. Normoxic tissues may be spared due to the hypoxia-specific activity of this agent, potentially reducing systemic toxicity. (NCI Thesaurus)
YOU MAY ALSO LIKE
A proprietary, hypoxia-activated prodrug with potential antineoplastic activity. Upon administration, the hypoxia-activated prodrug PR610 is activated in the hypoxic cells within tumors…
Highly expressed in secretory tissues (liver and pancreas) by human HYOU1 Gene (HSP70 Family), hypoxia-induced 999-aa (precursor) 150 kD Hypoxia Up-Regulated 1…
Hypoxic stress, like DNA damage, induces p53 protein accumulation and p53-dependent apoptosis in oncogenically transformed cells. Unlike DNA damage, hypoxia does not…
A condition in which there is a decrease in the oxygen supply to a tissue. In cancer treatment, the level of hypoxia…
A condition in which there is not enough oxygen in the blood.
Hypoxanthine-guanine phosphoribosyltransferase (218 aa, ~25 kDa) is encoded by the human HPRT1 gene. This protein plays a role in nucleoside metabolism. …
